This article was reviewed by Felix Gussone, MD. Key Takeaways: In the U.S., testosterone is a controlled substance, so you’ll ...

THREE quarters of cancer patients will beat the disease under plans to boost NHS care, Wes Streeting has pledged. He aims to have 75 per cent of those diagnosed from 2035 onwards either cured or ...

Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...

Steve Jones was left with an unwanted side effect after undergoing surgery for prostate cancer: erectile dysfunction that ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Black Californians are five times more likely than others to die of prostate cancer. Gov. Gavin Newsom vetoed a bill that would have cut screening costs.

Investigators trialed injection of an immune-stimulating substance (poly-ICLC) into the prostate gland using MRI-ultrasound fusion technology in patients scheduled to undergo radical prostatectomy.

(UroToday.com) The 2025 European Society for Medical Oncology (ESMO) Annual Congress, held in Berlin, Germany, was host to a prostate cancer poster session. Dr. Jose Avitia presented the results of a ...

Botox can reduce the number of headache days for people with chronic migraines. Treatment involves Botox injections into 31 different sites on the head, face, and neck every 12 weeks. Common side ...

The MarketWatch News Department was not involved in the creation of this content. St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC ...